Cargando…
CTP Synthase 1 Is a Novel Therapeutic Target in Lymphoma
Lymphoma is the most common hematological malignancy and is among the 10 most prevalent cancers worldwide. Although survival has been improved by modern immunochemotherapeutic regimens, there remains a significant need for novel targeted agents to treat both B-cell and T-cell malignancies. Cytidine...
Autores principales: | Asnagli, Hélène, Minet, Norbert, Pfeiffer, Christina, Hoeben, Eef, Lane, Rebecca, Laughton, David, Birch, Louise, Jones, Geraint, Novak, Andrew, Parker, Andrew E., Ludwig, Heinz, Fischer, Alain, Latour, Sylvain, Beer, Philip A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060080/ https://www.ncbi.nlm.nih.gov/pubmed/37008165 http://dx.doi.org/10.1097/HS9.0000000000000864 |
Ejemplares similares
-
Differential roles of CTP synthetases CTPS1 and CTPS2 in cell proliferation
por: Minet, Norbert, et al.
Publicado: (2023) -
P1248: CTP SYNTHASE 1 IS A NOVEL TARGET IN T CELL CANCERS, WITH SMALL MOLECULE INHIBITION INDUCING DEATH OF NEOPLASTIC HUMAN T CELLS IN VITRO AND INHIBITION OF THEIR GROWTH IN AN IN VIVO XENOTRANSPLANT MODEL
por: Beer, P., et al.
Publicado: (2022) -
P1308: SELECTIVE SMALL MOLECULE INHIBITION OF CTP SYNTHASE 1 (CTPS1) SUPPRESSES T CELL PROLIFERATION AND CYTOKINE RELEASE, HIGHLIGHTING A NOVEL THERAPEUTIC TARGET FOR GRAFT-VERSUS-HOST DISEASE
por: Beer, P., et al.
Publicado: (2022) -
CTP synthase 1 deficiency in humans reveals its central role in lymphocyte proliferation
por: Martin, Emmanuel, et al.
Publicado: (2014) -
CTP synthase: the hissing of the cellular serpent
por: Thangadurai, Shallinie, et al.
Publicado: (2022)